KKR Reports Monday. Prices Land Tuesday. Then Lenders Set Terms on Theramex and AI.

Last week, stocks fell fast and credit held.

The S&P 500 fell 4.36% on Thursday. The largest high-yield bond fund (HYG) lost about 0.3%. Private money kept committing, on terms that protect it. Oracle (ORCL) paid up to 8.65% on new notes. Blackstone (BX) took structured equity in Shield AI.

Then Friday's report showed 165,000 jobs added in October, far above the 65,000 expected. Unemployment fell to 4.1%. December hike odds rose back near 77%. The Fed decides Dec. 9.

This week, the price of money gets set in public again. Below are the six places capital needs to be priced next. Each is marked scheduled or open-ended. All times are Eastern.

KKR Reports Monday. Is It Lending More and Selling Enough?

KKR (KKR) reports Monday and holds its call at 10 a.m. It closes out the big managers' third-quarter reports.

The bar is set. Apollo (APO) originated a record $114 billion, while its flagship buyout strategy lost 2.6% before fees. Carlyle (CG)'s funds realized $9 billion last quarter. Accounts advised by KKR helped anchor SpaceX's $40 billion chip lease last month.

Pricing is the pressure point. In a Bloomberg Intelligence survey, most investors now expect private credit to pay at most 1 point over syndicated loans. Most managers still expect 2 points or more.

What to Watch

Listen for what KKR's new loans pay and how much it sold. Realizations near Carlyle's pace would show exits are opening. Record lending at thinner spreads would mean managers are growing fees by taking less per loan.

Prices Land Tuesday. Will Floating Coupons Rise in December?

October consumer prices land Tuesday. The Treasury sells $125 billion of notes and bonds across three sales. Three-year notes go Monday, 10-year notes Tuesday and 30-year bonds Thursday. Fed minutes follow Nov. 18.

Floating-rate private loans are exposed first. A hike on Dec. 9 would lift their coupons directly. Long yields matter for refinancing. The 10-year closed near 4.89% last Monday, its lowest since early September. Treasury dropped two words from its guidance on holding auction sizes steady. Its advisers say bigger auctions will be needed later this fiscal year. AI borrowers are competing for the same long money. Oracle (ORCL)'s new notes pay 7% to 8.65%, and its 2066 bonds fell more than a point the day after it priced.

What to Watch

A hot core reading would lock in December and lift what borrowers pay on new loans. A soft one would reopen the question after the jobs beat. Weak demand at Thursday's 30-year sale would push the long end up, which buyout refinancing feels.

Evergreen Funds Face Their Next Exit Windows. Can Banks Still Help?

Partners Group's U.S. evergreen fund closes its next exit window Nov. 27. Last quarter, investors asked for $2.2 billion and got about a third. Cox Capital's bid for Blue Owl Credit Income Corp. shares, 20% under stated value, runs to Nov. 25.

The backstop is thinner. Banks tightened standards on every type of loan to nonbank lenders the Fed asked about, including private equity funds. And lenders holding the same loans disagree on their value more often.

Distressed bids have dates, too. Bids for an Outback franchisee are due Dec. 8. Bloomin' Brands (BLMN) opened at $26.3 million against about $320 million of debts.

What to Watch

Requests at Partners Group, disclosed in a later filing, will show if last quarter was a spike or a queue. More selling into Cox's 20% discount would show what waiting now costs.

Lenders Are Being Asked to Fund Three Big Buyouts. At What Size?

No date is set. Cinven is asking banks for about €1.5 billion to buy Theramex, nearly 60% of the reported €2.6 billion price. MUFG underwrites up to €2.8 billion for Adani's purchase of Evos at 11.7 times EBITDA. The Andersons (ANDE) is funding all of its $915 million ethanol deal with debt.

Venture deals now carry bank debt too. JPMorgan (JPM) arranged $500 million for Shield AI's purchase of Echodyne. Kraft Heinz's coffee buyer, One Rock, has not said how it will pay. Banks that commit are exposed until they sell the loans on. So are sponsors whose returns rest on the leverage.

What to Watch

A Theramex package that sells at full size would show banks still fund European health care buyouts. A cut in size or wider pricing would show the stock rout reaching loans. Steady junk bonds so far point to the first.

Thinking Machines May Close This Week. Will AI Rounds Hold Price?

Thinking Machines is raising $5 billion at $40 billion, a report said, and could close as soon as this week. Past talks near $50 billion did not go ahead. OpenAI's round is still open at $1.25 trillion, with about $11 billion committed toward as much as $20 billion. Baseten is raising at two prices, $26 billion and $30 billion.

Lenders are in the mix too. Amazon (AMZN)'s secured facility of up to about $80 billion has no named lenders yet.

What to Watch

A Thinking Machines close at $40 billion would set a lower bar for AI labs without a down round. OpenAI's first close and investor list will show how much of the $20 billion is real. Shield AI's filing could show what Blackstone's structured equity is owed.

Holders With Control Face Their Next Tests.

EVgo (EVGO) is expected to report Monday. Its committee is weighing LS Power's $2 proposal. LS Power holds about 56% of the vote and says it will not sell. EQT's Kakaku offer runs to Nov. 12, against a Bain group's higher proposal. ADT (ADT)'s go-shop ends Nov. 28.

Two bids have no date. Silver Lake and PIF discussed Unity at about $25 billion, a report said. Helen of Troy's board rejected $37 a share, and the stock trades just above it.

Stock offers keep moving with the buyer. Marvell (MRVL)'s offer for Lumentum (LITE) was worth about $771 a share last Monday, against a $1,132 headline.

What to Watch

A vote of EVgo's other holders in any firm deal would be the protection to look for. A formal Unity process would test whether $25 billion holds after the selloff. A higher Helen of Troy bid would justify the stock's price. Without one, it could fall back. Lumentum's gap to Marvell's offer will show whether holders trust a stock deal in a falling market.